We are live on
!
Find out more
C
Consulta Portfolio holdings
AUM
$2.77B
1-Year Est. Return
3.62%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
+3.62%
3 Year Est. Return
+30.69%
5 Year Est. Return
+30.14%
10 Year Est. Return
+206.35%
AUM
$1.52B
AUM Growth
+$127M
(+9.1%)
Cap. Flow
+$8.94M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
83.74%
Holding
14
New
1
Increased
2
Reduced
4
Closed
–
Avg Time Held
11.5
quarters
Top 10 Avg Time Held
9.7
quarters
Top 20 Avg Time Held
11.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$48.7M |
| 2 |
HCA Healthcare
HCA
|
+$37.1M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$40M |
| 2 |
Visa
V
|
+$24.6M |
| 3 |
JPMorgan Chase
JPM
|
+$22.7M |
| 4 |
Danaher
DHR
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.3% |
| 2 | Financials | 20.53% |
| 3 | Communication Services | 19.44% |
| 4 | Industrials | 11.82% |
| 5 | Consumer Discretionary | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alphabet (Google) Class A
GOOGL
$4.29T
| $175M | 11.5% |
1,250,000
| – | – |
2017 Q2
26 quarters
|
|
|
2
UnitedHealth
UNH
$337B
| $158M | 10.4% |
300,000
-75,000
| -20% | -$40M |
2019 Q3
17 quarters
|
|
|
3
Visa
V
$699B
| $156M | 10.29% |
600,000
-100,000
| -14% | -$24.6M |
2020 Q1
15 quarters
|
|
|
4
HCA Healthcare
HCA
$95.1B
| $135M | 8.91% |
500,000
+150,000
| +43% | +$37.1M |
2015 Q3
33 quarters
|
|
5
Comcast
CMCSA
$74.3B
| $121M | 7.94% |
2,750,000
| – | – |
2015 Q4
32 quarters
|
|
|
6
Danaher
DHR
$154B
| $116M | 7.62% |
500,000
-64,000
| -11% | -$13.6M |
2022 Q4
4 quarters
|
|
7
Lowe's Companies
LOW
$102B
| $111M | 7.33% |
500,000
| – | – |
2023 Q1
3 quarters
|
|
|
8
JPMorgan Chase
JPM
$876B
| $102M | 6.72% |
600,000
-150,000
| -20% | -$22.7M |
2022 Q4
4 quarters
|
|
9
Canadian National Railway
CNI
$69.9B
| $101M | 6.62% |
800,000
| – | – |
2021 Q3
9 quarters
|
|
10
Microsoft
MSFT
$3.93T
| $97.6M | 6.43% |
259,500
| – | – |
2022 Q3
5 quarters
|
|
11
Canadian Pacific Kansas City
CP
$73.5B
| $79.1M | 5.21% |
1,000,000
| – | – |
2022 Q2
6 quarters
|
|
|
12
Thermo Fisher Scientific
TMO
$245B
| $66.3M | 4.37% |
125,000
+50,000
| +67% | +$24.2M |
2023 Q2
2 quarters
|
|
13
Berkshire Hathaway Class B
BRK.B
$1.08T
| $53.5M | 3.52% |
150,000
| – | – |
2022 Q3
5 quarters
|
|
|
14
Starbucks
SBUX
$107B
| $48M | 3.16% |
+500,000
| New | +$48.7M |
2023 Q4
0 quarters
|
|
Similar funds
HCM
BGM
SIM
JHP
DJSG
CAAS
CCM
FFA
Consulta's Q4 2023 Portfolio in Review
As of Q4 2023, Consulta held 14 positions worth $1.52B, up 9.1% from $1.39B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Consulta's Q4 2023 filing shows 1 new, 2 increased and 4 reduced positions. Its largest new stake was Starbucks: 500,000 shares worth $48M. The largest sale was UnitedHealth, an estimated $40M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.
- Consulta's largest Q4 2023 buy was Starbucks: 500,000 shares worth $48M.
- Consulta added most to HCA Healthcare in Q4 2023, an estimated $37.1M increase.
- Consulta's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $40M.
- Consulta's ten largest holdings make up 84% of its $1.52B portfolio in Q4 2023.
- Consulta opened 1 new position and closed 0 in Q4 2023.
- Consulta's portfolio value rose 9.1% quarter-over-quarter to $1.52B.
Based on Consulta's 13F filing for Q4 2023, filed 14 Feb 2024.